Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Type 2 diabetes mellitus (T2DM) remains a major global health challenge, and although mesenchymal stem cell (MSC)-based therapy has shown promise in targeting its core pathological features, its translational potential is limited by unstable efficacy, including limited therapeutic durability and marked variability associated with baseline insulin secretion and β-cell reserve.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
